NCT06528197

Brief Summary

This study aims to establish a large sample cohort of patients with primary sjogren's syndrome, collect multi-omics information of patients with primary sjogren's syndrome, and construct disease diagnosis model and disease prognosis prediction model.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jul 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jul 2024Dec 2026

Study Start

First participant enrolled

July 4, 2024

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

July 12, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 30, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

1.5 years

First QC Date

July 12, 2024

Last Update Submit

July 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with system involvement

    System involvement determined from clinical diagnosis

    Baseline , 6 months follow-up

Secondary Outcomes (3)

  • Mortality

    Baseline , 6 months follow-up

  • Number of participants with tumor

    Baseline , 6 months follow-up

  • Number of participants with connective tissue disease

    Baseline , 6 months follow-up

Study Arms (2)

Exposed group

Control group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with primary Sjögren's syndrome

You may qualify if:

  • Meets the 2002 AECG or 2016 ACR/EULAR classification criteria of primary Sjögren's syndrome.

You may not qualify if:

  • Comorbid connective tissue disease other than the disease under research.
  • Women who are pregnant or breastfeeding.
  • Combined severe cardiovascular or cerebrovascular disease, hepatic or renal failure, or severe malignant tumors.
  • Other conditions (e.g., cognitive impairment) that the investigators consider ineligible for enrollment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jiaqi Chen

Beijing, Beijing Municipality, 100029, China

RECRUITING

Related Publications (1)

  • Lei C, Zhang X, Zhang Y, Fang Y, Chen J, Liu Z, Zhou X, Tang B, Liao J, Huang Z, Yang J, Wang Z, Liu T, Tao Q, Luo J. Sex differences in primary Sjogren's disease: prognostic impact on mortality and cancer. Biol Sex Differ. 2026 Jan 14. doi: 10.1186/s13293-026-00827-7. Online ahead of print.

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
30 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief physician

Study Record Dates

First Submitted

July 12, 2024

First Posted

July 30, 2024

Study Start

July 4, 2024

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

July 30, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations